4.7 Article

Pharmacological anti-tumor effects of natural Chamaecyparis obtusa (siebold & zucc.) endl. Leaf extracts on breast cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Plant Sciences

Chamaecyparis obtusa (Siebold & Zucc.) Endl. leaf extracts prevent inflammatory responses via inhibition of the JAK/STAT axis in RAW264.7 cells

Yong-Jin Kwon et al.

Summary: The study demonstrates that Chamaecyparis obtusa leaf extract inhibits the expression of inflammatory mediators and cytokines, as well as directly inhibiting the activation of the inflammatory pathway. These findings suggest the potential therapeutic use of C. obtusa extracts in inflammatory diseases.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Review Oncology

STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential

Sarah Q. To et al.

Summary: This review explores the role of the STAT3 signaling pathway in breast cancer and its correlation with disease progression and metastasis. The study discusses the function of this signaling cascade in the tumor microenvironment, as well as the contribution of IL-6 family cytokines to cancer and potential therapeutic targets.

CANCERS (2022)

Review Oncology

Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance

Taniya Saha et al.

Summary: Breast cancer is the most common malignancy in women worldwide, and drug resistance remains a major challenge. Breast cancer is heterogeneous, with cancer-initiating stem-like cells (bCSCs) playing a role in resistance and invasiveness. Treatment of breast cancer includes surgery, radiotherapy, and systemic therapies. However, the crosstalk between malignant cells and the breast tumor microenvironment, as well as dysregulated miRNAs/ncRNAs patterns in bCSCs, contribute to drug resistance. Targeting bCSCs to reverse drug resistance and increase drug sensitivity is a promising approach in breast cancer research.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells

Yong-Jin Kwon et al.

Summary: Under conditions of tumor acidosis, the expression of PD-L1 significantly increases and it is likely mediated by activation of the STAT3 signaling pathway. This finding provides new insights into the study of tumor immune evasion mechanisms.

BMC CANCER (2022)

Review Oncology

Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review)

Rui-Jie Ma et al.

Summary: Esophageal cancer (EC) is a common cancer with poor prognosis. STAT3 activation plays a crucial role in promoting cancer cell proliferation and therapy resistance in EC, and non-coding RNAs are involved in regulating the STAT3 signaling pathway. Targeting STAT3 may provide novel therapeutic strategies for EC.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Article Nutrition & Dietetics

Combination of Ashwagandha Water Extract and Intermittent Fasting as a Therapy to Overcome Cisplatin Resistance in Breast Cancer: An in vitro and in vivo Study

Sajidah Jawarneh et al.

Summary: Breast cancer is a major public health issue for women worldwide. Conventional anticancer therapies often have high toxicity and low selectivity, leading to a growing interest in using plant-derived natural products for cancer prevention and treatment. This study explored the combination of ashwagandha extract and intermittent fasting as a potential solution for breast cancer treatment. The results showed that the combination had a synergistic effect on inhibiting the proliferation of cancer cells and inducing apoptosis. In addition, the combination treatment was found to be safe and minimized the toxicity to the liver and kidney. These findings suggest that the combination of ashwagandha extract and intermittent fasting could be a promising alternative for breast cancer treatment.

FRONTIERS IN NUTRITION (2022)

Review Biochemistry & Molecular Biology

Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer

Pourya Sarvari et al.

Summary: Epigenetic modifications play a crucial role in breast cancer progression, and a better understanding of these modifications could lead to new therapeutic approaches. This review outlines different epigenetic mechanisms and discusses their impact on breast cancer pathogenesis, highlighting the potential of locus-specific epigenome editing as a treatment strategy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Symptom Management and Quality of Life of Breast Cancer Patients Using Acupuncture-Related Therapies and Herbal Medicine: A Scoping Review

Gajin Han et al.

Summary: This is a scoping review of the usefulness of acupuncture-related therapies and herbal medicine in alleviating the side effects of breast cancer treatments. The study found positive impact of these therapies in improving symptoms and quality of life in patients with breast cancer, and suggests further research on their economic impact.

CANCERS (2022)

Review Cell Biology

Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance

Shigeru Hashimoto et al.

Summary: It is well-known that cancer-associated inflammation contributes to tumor initiation and progression. However, the balance between antitumor immunity and protumor immunity in the immune system and the role of STAT3 activation in cancer malignancy are still not clear. This paper reviews recent advances in understanding the functional role of STAT3 in tumor progression and introduces new molecular mechanisms of cancer development and malignant transformation involving STAT3 activation.
Article Gastroenterology & Hepatology

Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development

Eun-Bi Seo et al.

Summary: Phospholipase C gamma 1 (PLC gamma 1) plays an oncogenic role in hepatocellular carcinoma (HCC) by regulating the activation of STAT3 signaling. Deletion of PLC gamma 1 effectively prevents DEN-induced HCC and reduces tumor burden and progression.

HEPATOLOGY COMMUNICATIONS (2022)

Review Medicine, Research & Experimental

STAT3 pathway in cancers: Past, present, and future

Han-Qi Wang et al.

Summary: This review provides an overview of the history, research advances, and prospects of the STAT3 pathway in cancer. It discusses the mechanisms of STAT3 pathway regulation, the cancer hallmarks induced by this pathway, and the emerging development of inhibitors and drug delivery systems targeting STAT3. The review also addresses the barriers and promising targets in the STAT3 pathway, as well as the overall utility of STAT3 pathway inhibitors in cancer treatment.

MEDCOMM (2022)

Article Biochemistry & Molecular Biology

α-Pinene Enhances the Anticancer Activity of Natural Killer Cells via ERK/AKT Pathway

Hantae Jo et al.

Summary: The study focused on the role of phytoncides in activating NK cells and enhancing anticancer effects. Results showed that alpha-pinene treatment increased NK cell cytotoxicity and inhibited tumor growth, suggesting its potential in cancer immunotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Chemistry, Medicinal

The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy

Manoj Garg et al.

Summary: The review discusses the regulation of STAT3 signaling and its association with the development of both solid and hematological malignancies. It also mentions various ways to target oncogenic STAT3 signaling using small molecules derived from natural products.

MEDICINAL RESEARCH REVIEWS (2021)

Article Biodiversity Conservation

Impact of Hinoki Cypress Wood on Diversity of Microflora: A Case Study from Owase City Hall

Daisuke Tanaka et al.

Summary: This study evaluated the antimicrobial effects of Hinoki cypress against airborne microorganisms, finding that it has some antifungal effects and may be a useful functional material in building environments.

DIVERSITY-BASEL (2021)

Review Nutrition & Dietetics

Flavonoids as Anticancer Agents

Dalia M. Kopustinskiene et al.

NUTRIENTS (2020)

Article Biochemistry & Molecular Biology

Pygenic Acid A (PA) Sensitizes Metastatic Breast Cancer Cells to Anoikis and Inhibits Metastasis In Vivo

Ga-Eun Lim et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

Jiang-Jiang Qin et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Medicine, General & Internal

Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy

Byung-Hak Kim et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Chemistry, Medicinal

Discovery of potential antiausterity agents from the Japanese cypress Chamaecyparis obtusa

Dya Fita Dibwe et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

Review Oncology

Constitutive activation of STAT3 in breast cancer cells: A review

Kasturi Banerjee et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Review Biotechnology & Applied Microbiology

Role of STAT3 in Cancer Metastasis and Translational Advances

Mohammad Zahid Kamran et al.

BIOMED RESEARCH INTERNATIONAL (2013)

Article Immunology

EFFECT OF PHYTONCIDE FROM TREES ON HUMAN NATURAL KILLER CELL FUNCTION

Q. Li et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)

Review Oncology

Breast cancer metastasis: Markers and models

B Weigelt et al.

NATURE REVIEWS CANCER (2005)

Review Cell Biology

STATs: Transcriptional control and biological impact

DE Levy et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)